aluates Reports

$ 0.0

Automative

Global Aminoglycosides Antibiotics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-23W8840

Global Aminoglycosides Antibiotics Market Outlook 2022

BUY CHAPTERS

Global Aminoglycosides Antibiotics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-23W8840

Report

June 2025

Pages:158

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Jemicare

TEVA

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla Ltd

Pfizer Inc

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

Aminoglycosides Antibiotics Market Size

In 2024, the global market size of Aminoglycosides Antibiotics was estimated to be worth US$ 733 million and is forecast to reach approximately US$ 675 million by 2031 with a CAGR of -1.2% during the forecast period 2025-2031.

Aminoglycosides Antibiotics Market

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms.

The key players of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis and Fangyuan-pharma. The top four manufacturers hold approximately 15% of the global market share,.

In terms of product type, Tobramycin is the largest segment, with a share of 34%. And in terms of application, Hospital has a share about 38 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aminoglycosides Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycosides Antibiotics.

The Aminoglycosides Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aminoglycosides Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aminoglycosides Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Aminoglycosides Antibiotics Market Report

Report Metric	Details
Report Name	Aminoglycosides Antibiotics Market
Forecasted market size in 2031	approximately US$ 675 million
Forecasted years	2025 - 2031
Segment by Type	Tobramycin Gentamicin Amikacin Etimicin Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Aminoglycosides Antibiotics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Aminoglycosides Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aminoglycosides Antibiotics sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Aminoglycosides Antibiotics Market size in 2031?

Ans: The Aminoglycosides Antibiotics Market size in 2031 will be approximately US$ 675 million.

What is the market share of major companies in Aminoglycosides Antibiotics Market?

Ans: The top four manufacturers hold approximately 15% of the global market share,.

What is the Aminoglycosides Antibiotics Market share by type?

Ans: In terms of product type, Tobramycin is the largest segment, with a share of 34%.

Who are the main players in the Aminoglycosides Antibiotics Market report?

Ans: The main players in the Aminoglycosides Antibiotics Market are Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company

What are the Application segmentation covered in the Aminoglycosides Antibiotics Market report?

Ans: The Applications covered in the Aminoglycosides Antibiotics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Aminoglycosides Antibiotics Market report?

Ans: The Types covered in the Aminoglycosides Antibiotics Market report are Tobramycin, Gentamicin, Amikacin, Etimicin, Others

1 Study Coverage

1.1 Aminoglycosides Antibiotics Product Introduction

1.2 Market by Type

1.2.1 Global Aminoglycosides Antibiotics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Tobramycin

1.2.3 Gentamicin

1.2.4 Amikacin

1.2.5 Etimicin

1.2.6 Others

1.3 Market by Application

1.3.1 Global Aminoglycosides Antibiotics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Aminoglycosides Antibiotics Market Size Estimates and Forecasts

2.1.1 Global Aminoglycosides Antibiotics Revenue 2020-2031

2.1.2 Global Aminoglycosides Antibiotics Sales 2020-2031

2.2 Aminoglycosides Antibiotics Market Size by Region: 2024 Versus 2031

2.3 Aminoglycosides Antibiotics Sales by Region (2020-2031)

2.3.1 Global Aminoglycosides Antibiotics Sales by Region: 2020-2025

2.3.2 Global Aminoglycosides Antibiotics Sales Forecast by Region (2026-2031)

2.3.3 Global Aminoglycosides Antibiotics Sales Market Share by Region (2020-2031)

2.4 Aminoglycosides Antibiotics Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Aminoglycosides Antibiotics Revenue by Region: 2020-2025

2.4.2 Global Aminoglycosides Antibiotics Revenue Forecast by Region (2026-2031)

2.4.3 Global Aminoglycosides Antibiotics Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Aminoglycosides Antibiotics Sales by Type (2020-2031)

3.1.1.1 Global Aminoglycosides Antibiotics Sales Volume by Type (2020-2031)

3.1.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Type (2020-2031)

3.1.2 Global Aminoglycosides Antibiotics Revenue by Type (2020-2031)

3.1.2.1 Global Aminoglycosides Antibiotics Revenue by Type (2020-2031)

3.1.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2020-2031)

3.1.3 Aminoglycosides Antibiotics Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Aminoglycosides Antibiotics Sales by Application (2020-2031)

3.2.1.1 Global Aminoglycosides Antibiotics Sales Volume by Application (2020-2031)

3.2.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Application (2020-2031)

3.2.2 Global Aminoglycosides Antibiotics Revenue by Application (2020-2031)

3.2.2.1 Global Aminoglycosides Antibiotics Revenue by Application (2020-2031)

3.2.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2020-2031)

3.2.3 Aminoglycosides Antibiotics Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Tobramycin of Aminoglycosides Antibiotics Revenue Market Share by Application

3.3.2 Gentamicin of Aminoglycosides Antibiotics Revenue Market Share by Application

3.3.3 Amikacin of Aminoglycosides Antibiotics Revenue Market Share by Application

3.3.4 Etimicin of Aminoglycosides Antibiotics Revenue Market Share by Application

3.3.5 Others of Aminoglycosides Antibiotics Revenue Market Share by Application

4 Global Aminoglycosides Antibiotics by Manufacturers

4.1 Global Top Aminoglycosides Antibiotics Manufacturers by Sales (2020-2025)

4.1.1 Global Aminoglycosides Antibiotics Sales by Manufacturer (2020-2025)

4.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Aminoglycosides Antibiotics Manufacturers by Revenue (2020-2025)

4.2.1 Global Aminoglycosides Antibiotics Revenue by Manufacturer (2020-2025)

4.2.2 Global Aminoglycosides Antibiotics Revenue Share by Manufacturer (2020-2025)

4.3 Global Aminoglycosides Antibiotics Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Aminoglycosides Antibiotics Manufacturers Covered: Ranking by Revenue

4.4.2 Global Aminoglycosides Antibiotics Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Aminoglycosides Antibiotics Manufacturing Base Distribution, Product Type

4.5.1 Aminoglycosides Antibiotics Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Aminoglycosides Antibiotics Market

4.5.3 Manufacturers Aminoglycosides Antibiotics Product Type and Application

4.5.4 Tobramycin Market Sales of Aminoglycosides Antibiotics by Manufacturer

4.5.5 Gentamicin Market Sales of Aminoglycosides Antibiotics by Manufacturer

4.5.6 Amikacin Market Sales of Aminoglycosides Antibiotics by Manufacturer

4.5.7 Etimicin Market Sales of Aminoglycosides Antibiotics by Manufacturer

4.5.8 Others Market Sales of Aminoglycosides Antibiotics by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Jemicare

5.1.1 Jemicare Company Information

5.1.2 Jemicare Description, Business Overview

5.1.3 Jemicare Aminoglycosides Antibiotics Products Offered

5.1.4 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Jemicare Aminoglycosides Antibiotics Sales by Product in 2024

5.1.6 Jemicare Aminoglycosides Antibiotics Sales by Application in 2024

5.1.7 Jemicare Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.1.8 Jemicare Recent Developments

5.2 Teva

5.2.1 Teva Company Information

5.2.2 Teva Description, Business Overview

5.2.3 Teva Aminoglycosides Antibiotics Products Offered

5.2.4 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Teva Aminoglycosides Antibiotics Sales by Product in 2024

5.2.6 Teva Aminoglycosides Antibiotics Sales by Application in 2024

5.2.7 Teva Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.2.8 Teva Recent Developments

5.3 Novartis

5.3.1 Novartis Company Information

5.3.2 Novartis Description, Business Overview

5.3.3 Novartis Aminoglycosides Antibiotics Products Offered

5.3.4 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Novartis Aminoglycosides Antibiotics Sales by Product in 2024

5.3.6 Novartis Aminoglycosides Antibiotics Sales by Application in 2024

5.3.7 Novartis Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.3.8 Novartis Recent Developments

5.4 Fangyuan-pharma

5.4.1 Fangyuan-pharma Company Information

5.4.2 Fangyuan-pharma Description, Business Overview

5.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Products Offered

5.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Fangyuan-pharma Aminoglycosides Antibiotics Sales by Product in 2024

5.4.6 Fangyuan-pharma Aminoglycosides Antibiotics Sales by Application in 2024

5.4.7 Fangyuan-pharma Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.4.8 Fangyuan-pharma Recent Developments

5.5 Aike Pharmaceutical

5.5.1 Aike Pharmaceutical Company Information

5.5.2 Aike Pharmaceutical Description, Business Overview

5.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Products Offered

5.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Aike Pharmaceutical Aminoglycosides Antibiotics Sales by Product in 2024

5.5.6 Aike Pharmaceutical Aminoglycosides Antibiotics Sales by Application in 2024

5.5.7 Aike Pharmaceutical Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.5.8 Aike Pharmaceutical Recent Developments

5.6 Cipla

5.6.1 Cipla Company Information

5.6.2 Cipla Description, Business Overview

5.6.3 Cipla Aminoglycosides Antibiotics Products Offered

5.6.4 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Cipla Aminoglycosides Antibiotics Sales by Product in 2024

5.6.6 Cipla Aminoglycosides Antibiotics Sales by Application in 2024

5.6.7 Cipla Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.6.8 Cipla Recent Developments

5.7 Pfizer

5.7.1 Pfizer Company Information

5.7.2 Pfizer Description, Business Overview

5.7.3 Pfizer Aminoglycosides Antibiotics Products Offered

5.7.4 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Pfizer Aminoglycosides Antibiotics Sales by Product in 2024

5.7.6 Pfizer Aminoglycosides Antibiotics Sales by Application in 2024

5.7.7 Pfizer Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.7.8 Pfizer Recent Developments

5.8 Fresenius Kabi

5.8.1 Fresenius Kabi Company Information

5.8.2 Fresenius Kabi Description, Business Overview

5.8.3 Fresenius Kabi Aminoglycosides Antibiotics Products Offered

5.8.4 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Fresenius Kabi Aminoglycosides Antibiotics Sales by Product in 2024

5.8.6 Fresenius Kabi Aminoglycosides Antibiotics Sales by Application in 2024

5.8.7 Fresenius Kabi Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.8.8 Fresenius Kabi Recent Developments

5.9 Sun Pharma

5.9.1 Sun Pharma Company Information

5.9.2 Sun Pharma Description, Business Overview

5.9.3 Sun Pharma Aminoglycosides Antibiotics Products Offered

5.9.4 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Sun Pharma Aminoglycosides Antibiotics Sales by Product in 2024

5.9.6 Sun Pharma Aminoglycosides Antibiotics Sales by Application in 2024

5.9.7 Sun Pharma Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.9.8 Sun Pharma Recent Developments

5.10 Hikma

5.10.1 Hikma Company Information

5.10.2 Hikma Description, Business Overview

5.10.3 Hikma Aminoglycosides Antibiotics Products Offered

5.10.4 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.10.5 Hikma Aminoglycosides Antibiotics Sales by Product in 2024

5.10.6 Hikma Aminoglycosides Antibiotics Sales by Application in 2024

5.10.7 Hikma Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.10.8 Hikma Recent Developments

5.11 Lannett Company

5.11.1 Lannett Company Company Information

5.11.2 Lannett Company Description, Business Overview

5.11.3 Lannett Company Aminoglycosides Antibiotics Products Offered

5.11.4 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2020-2025)

5.11.5 Lannett Company Aminoglycosides Antibiotics Sales by Product in 2024

5.11.6 Lannett Company Aminoglycosides Antibiotics Sales by Application in 2024

5.11.7 Lannett Company Aminoglycosides Antibiotics Sales by Geographic Area in 2024

5.11.8 Lannett Company Recent Developments

6 North America

6.1 North America Aminoglycosides Antibiotics Market Size YoY Growth 2020-2031

6.2 North America Aminoglycosides Antibiotics Market Facts & Figures by Country

6.2.1 North America Aminoglycosides Antibiotics Sales by Country (2020-2031)

6.2.2 North America Aminoglycosides Antibiotics Revenue by Country (2020-2031)

6.3 North America Aminoglycosides Antibiotics Sales by Type (2020-2025)

6.4 North America Aminoglycosides Antibiotics Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Aminoglycosides Antibiotics Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Aminoglycosides Antibiotics Market Facts & Figures by Region

7.2.1 Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2020-2031)

7.2.2 Asia-Pacific Aminoglycosides Antibiotics Revenue by Region (2020-2031)

7.3 Asia-Pacific Aminoglycosides Antibiotics Sales by Type (2020-2025)

7.4 Asia-Pacific Aminoglycosides Antibiotics Sales by Application (2020-2025)

8 Europe

8.1 Europe Aminoglycosides Antibiotics Market Size YoY Growth 2020-2031

8.2 Europe Aminoglycosides Antibiotics Market Facts & Figures by Country

8.2.1 Europe Aminoglycosides Antibiotics Sales by Country (2020-2031)

8.2.2 Europe Aminoglycosides Antibiotics Revenue by Country (2020-2031)

8.3 Europe Aminoglycosides Antibiotics Sales by Type (2020-2025)

8.4 Europe Aminoglycosides Antibiotics Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Aminoglycosides Antibiotics Market Size YoY Growth 2020-2031

9.2 Latin America Aminoglycosides Antibiotics Market Facts & Figures by Country

9.2.1 Latin America Aminoglycosides Antibiotics Sales by Country (2020-2031)

9.2.2 Latin America Aminoglycosides Antibiotics Revenue by Country (2020-2031)

9.3 Latin America Aminoglycosides Antibiotics Sales by Type (2020-2025)

9.4 Latin America Aminoglycosides Antibiotics Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Aminoglycosides Antibiotics Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Aminoglycosides Antibiotics Market Facts & Figures by Country

10.2.1 Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2020-2031)

10.2.2 Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2020-2031)

10.3 Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2020-2025)

10.4 Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Aminoglycosides Antibiotics Supply Chain Analysis

11.2 Aminoglycosides Antibiotics Key Raw Materials and Upstream Suppliers

11.3 Aminoglycosides Antibiotics Clients Analysis

11.4 Aminoglycosides Antibiotics Sales Channel and Sales Model Analysis

11.4.1 Aminoglycosides Antibiotics Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Aminoglycosides Antibiotics Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Aminoglycosides Antibiotics Distributors

12 Aminoglycosides Antibiotics Market Dynamics

12.1 Aminoglycosides Antibiotics Industry Trends

12.2 Aminoglycosides Antibiotics Market Drivers

12.3 Aminoglycosides Antibiotics Market Challenges

12.4 Aminoglycosides Antibiotics Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Jemicare

TEVA

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla Ltd

Pfizer Inc

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

List of Tables

Table 1. Global Aminoglycosides Antibiotics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Aminoglycosides Antibiotics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Aminoglycosides Antibiotics Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Aminoglycosides Antibiotics Sales by Region (2020-2025) & (M Units)

Table 5. Global Aminoglycosides Antibiotics Sales Forecast by Region (2026-2031) & (M Units)

Table 6. Global Aminoglycosides Antibiotics Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Aminoglycosides Antibiotics Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Aminoglycosides Antibiotics Sales Volume by Type (2020-2025) & (M Units)

Table 9. Global Aminoglycosides Antibiotics Sales Volume by Type (2026-2031) & (M Units)

Table 10. Global Aminoglycosides Antibiotics Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Aminoglycosides Antibiotics Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Aminoglycosides Antibiotics Sales Volume by Application (2020-2025) & (M Units)

Table 13. Global Aminoglycosides Antibiotics Sales Volume by Application (2026-2031) & (M Units)

Table 14. Global Aminoglycosides Antibiotics Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Aminoglycosides Antibiotics Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Aminoglycosides Antibiotics Sales by Manufacturer (2020-2025) & (M Units)

Table 17. Global Aminoglycosides Antibiotics Sales Share by Manufacturer (2020-2025)

Table 18. Aminoglycosides Antibiotics Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Aminoglycosides Antibiotics Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Aminoglycosides Antibiotics Price (2020-2025) & (US$/Unit)

Table 21. Ranking of Global Top Aminoglycosides Antibiotics Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Aminoglycosides Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Aminoglycosides Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2024)

Table 24. Aminoglycosides Antibiotics Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Aminoglycosides Antibiotics Market

Table 26. Manufacturers Aminoglycosides Antibiotics Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Jemicare Company Information

Table 29. Jemicare Description and Business Overview

Table 30. Jemicare Aminoglycosides Antibiotics Product

Table 31. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 32. Jemicare Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 33. Jemicare Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 34. Jemicare Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 35. Jemicare Recent Developments

Table 36. Teva Company Information

Table 37. Teva Description and Business Overview

Table 38. Teva Aminoglycosides Antibiotics Product

Table 39. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 40. Teva Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 41. Teva Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 42. Teva Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 43. Teva Recent Developments

Table 44. Novartis Company Information

Table 45. Novartis Description and Business Overview

Table 46. Novartis Aminoglycosides Antibiotics Product

Table 47. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 48. Novartis Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 49. Novartis Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 50. Novartis Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 51. Novartis Recent Developments

Table 52. Fangyuan-pharma Company Information

Table 53. Fangyuan-pharma Description and Business Overview

Table 54. Fangyuan-pharma Aminoglycosides Antibiotics Product

Table 55. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 56. Fangyuan-pharma Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 57. Fangyuan-pharma Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 58. Fangyuan-pharma Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 59. Fangyuan-pharma Recent Developments

Table 60. Aike Pharmaceutical Company Information

Table 61. Aike Pharmaceutical Description and Business Overview

Table 62. Aike Pharmaceutical Aminoglycosides Antibiotics Product

Table 63. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 64. Aike Pharmaceutical Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 65. Aike Pharmaceutical Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 66. Aike Pharmaceutical Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 67. Aike Pharmaceutical Recent Developments

Table 68. Cipla Company Information

Table 69. Cipla Description and Business Overview

Table 70. Cipla Aminoglycosides Antibiotics Product

Table 71. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Cipla Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 73. Cipla Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 74. Cipla Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 75. Cipla Recent Developments

Table 76. Pfizer Company Information

Table 77. Pfizer Description and Business Overview

Table 78. Pfizer Aminoglycosides Antibiotics Product

Table 79. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Pfizer Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 81. Pfizer Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 82. Pfizer Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 83. Pfizer Recent Developments

Table 84. Fresenius Kabi Company Information

Table 85. Fresenius Kabi Description and Business Overview

Table 86. Fresenius Kabi Aminoglycosides Antibiotics Product

Table 87. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Fresenius Kabi Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 89. Fresenius Kabi Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 90. Fresenius Kabi Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 91. Fresenius Kabi Recent Developments

Table 92. Sun Pharma Company Information

Table 93. Sun Pharma Description and Business Overview

Table 94. Sun Pharma Aminoglycosides Antibiotics Product

Table 95. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 96. Sun Pharma Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 97. Sun Pharma Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 98. Sun Pharma Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 99. Sun Pharma Recent Developments

Table 100. Hikma Company Information

Table 101. Hikma Description and Business Overview

Table 102. Hikma Aminoglycosides Antibiotics Product

Table 103. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Hikma Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 105. Hikma Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 106. Hikma Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 107. Hikma Recent Developments

Table 108. Lannett Company Company Information

Table 109. Lannett Company Description and Business Overview

Table 110. Lannett Company Aminoglycosides Antibiotics Product

Table 111. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 112. Lannett Company Sales Proportion of Aminoglycosides Antibiotics by Product in 2024

Table 113. Lannett Company Sales Proportion of Aminoglycosides Antibiotics by Application in 2024

Table 114. Lannett Company Sales Proportion of Aminoglycosides Antibiotics by Geographic Area in 2024

Table 115. Lannett Company Recent Developments

Table 116. North America Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)

Table 117. North America Aminoglycosides Antibiotics Sales by Country (2026-2031) & (M Units)

Table 118. North America Aminoglycosides Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 119. North America Aminoglycosides Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 120. North America Aminoglycosides Antibiotics Sales by Type (2020-2025) & (M Units)

Table 121. North America Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)

Table 122. Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2020-2025) & (M Units)

Table 123. Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2026-2031) & (M Units)

Table 124. Asia-Pacific Aminoglycosides Antibiotics Revenue by Region (2020-2025) & (US$ Million)

Table 125. Asia-Pacific Aminoglycosides Antibiotics Revenue by Region (2026-2031) & (US$ Million)

Table 126. Asia-Pacific Aminoglycosides Antibiotics Sales by Type (2020-2025) & (M Units)

Table 127. Asia-Pacific Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)

Table 128. Europe Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)

Table 129. Europe Aminoglycosides Antibiotics Sales by Country (2026-2031) & (M Units)

Table 130. Europe Aminoglycosides Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 131. Europe Aminoglycosides Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 132. Europe Aminoglycosides Antibiotics Sales by Type (2020-2025) & (M Units)

Table 133. Europe Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)

Table 134. Latin America Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)

Table 135. Latin America Aminoglycosides Antibiotics Sales by Country (2026-2031) & (M Units)

Table 136. Latin America Aminoglycosides Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 137. Latin America Aminoglycosides Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 138. Latin America Aminoglycosides Antibiotics Sales by Type (2020-2025) & (M Units)

Table 139. Latin America Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)

Table 140. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2020-2025) & (M Units)

Table 141. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2026-2031) & (M Units)

Table 142. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 143. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 144. Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2020-2025) & (M Units)

Table 145. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2020-2025) & (M Units)

Table 146. Aminoglycosides Antibiotics Key Raw Materials, Industry Status and Trend

Table 147. Aminoglycosides Antibiotics Key Raw Materials and Upstream Suppliers

Table 148. Aminoglycosides Antibiotics Clients Status and Trend

Table 149. Aminoglycosides Antibiotics Typical Clients

Table 150. Aminoglycosides Antibiotics Distributors

Table 151. Aminoglycosides Antibiotics Market Trends

Table 152. Aminoglycosides Antibiotics Market Drivers

Table 153. Aminoglycosides Antibiotics Market Challenges

Table 154. Aminoglycosides Antibiotics Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

Table 158. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Aminoglycosides Antibiotics Product Picture

Figure 2. Global Aminoglycosides Antibiotics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Aminoglycosides Antibiotics Sales Market Share by Type in 2024 & 2031

Figure 4. Tobramycin Product Picture

Figure 5. Gentamicin Product Picture

Figure 6. Amikacin Product Picture

Figure 7. Etimicin Product Picture

Figure 8. Others Product Picture

Figure 9. Global Aminoglycosides Antibiotics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 10. Global Aminoglycosides Antibiotics Sales Market Share by Application in 2024 & 2031

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Others

Figure 14. Aminoglycosides Antibiotics Report Years Considered

Figure 15. Global Aminoglycosides Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Aminoglycosides Antibiotics Market Size 2020-2031 (US$ Million)

Figure 17. Global Aminoglycosides Antibiotics Sales 2020-2031 (M Units)

Figure 18. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Region (2020-2031)

Figure 19. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2020-2031)

Figure 20. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Type (2020-2031)

Figure 21. Global Aminoglycosides Antibiotics Revenue Market Share Forecast by Type (2020-2031)

Figure 22. Aminoglycosides Antibiotics Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)

Figure 23. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Application (2020-2031)

Figure 24. Global Aminoglycosides Antibiotics Revenue Market Share Forecast by Application (2020-2031)

Figure 25. Aminoglycosides Antibiotics Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)

Figure 26. Tobramycin of Aminoglycosides Antibiotics Revenue Market Share by Application, 2024 VS 2031

Figure 27. Gentamicin of Aminoglycosides Antibiotics Revenue Market Share by Application, 2024 VS 2031

Figure 28. Amikacin of Aminoglycosides Antibiotics Revenue Market Share by Application, 2024 VS 2031

Figure 29. Etimicin of Aminoglycosides Antibiotics Revenue Market Share by Application, 2024 VS 2031

Figure 30. Others of Aminoglycosides Antibiotics Revenue Market Share by Application, 2024 VS 2031

Figure 31. Global Aminoglycosides Antibiotics Sales Share by Manufacturer in 2024

Figure 32. Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 33. Tobramycin Market Sales Proportion by Manufacturer in 2024

Figure 34. Gentamicin Market Sales Proportion by Manufacturer in 2024

Figure 35. Amikacin Market Sales Proportion by Manufacturer in 2024

Figure 36. Etimicin Market Sales Proportion by Manufacturer in 2024

Figure 37. Others Market Sales Proportion by Manufacturer in 2024

Figure 38. North America Aminoglycosides Antibiotics Revenue 2020-2031 (US$ Million)

Figure 39. North America Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)

Figure 40. North America Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)

Figure 41. Asia-Pacific Aminoglycosides Antibiotics Revenue 2020-2031 (US$ Million)

Figure 42. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share by Region (2020-2031)

Figure 43. Asia-Pacific Aminoglycosides Antibiotics Revenue Market Share by Region (2020-2031)

Figure 44. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)

Figure 45. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)

Figure 46. Europe Aminoglycosides Antibiotics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 47. Europe Aminoglycosides Antibiotics Sales Market Share by Country (2020-2031)

Figure 48. Europe Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2031)

Figure 49. Europe Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)

Figure 50. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)

Figure 51. Latin America Aminoglycosides Antibiotics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 52. Latin America Aminoglycosides Antibiotics Sales Market Share by Country (2020-2031)

Figure 53. Latin America Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2025)

Figure 54. Latin America Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)

Figure 55. Latin America Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)

Figure 56. Middle East and Africa Aminoglycosides Antibiotics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 57. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Country (2020-2031)

Figure 58. Middle East and Africa Aminoglycosides Antibiotics Revenue Market Share by Country (2020-2031)

Figure 59. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Type (2020-2025)

Figure 60. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Application (2020-2025)

Figure 61. Aminoglycosides Antibiotics Supply Chain (Upstream and Downstream Market)

Figure 62. Global Production Market Share of Aminoglycosides Antibiotics Raw Materials by Region in 2024

Figure 63. Aminoglycosides Antibiotics Distribution Channels

Figure 64. Global Aminoglycosides Antibiotics Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 65. Global Aminoglycosides Antibiotics Percentage 2020-2031: Online Sales VS Offline Sales

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Aminoglycosides Antibiotics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Aminoglycoside Antibiotics Market Research Report 2025

Global Tobramycin Sulfate Market Research Report 2024

Global Neomycin Sulfate API Market Research Report 2024

Global Netilmicin Sulfate API Market Research Report 2024

Global Gentamicin ELISA Kit Market Research Report 2024

Liposomal Amikacin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chloramphenicol Antibiotics Market Research Report 2024

Global Pediatric Antibiotics Market Research Report 2024

Global Dihydrostreptomycin Sulfate Market Research Report 2024

Global Carbapenem Drugs Market Research Report 2024

Amoxicillin Antibiotic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Penicillin Streptomycin Gentamicin Solution Market Research Report 2025

Global Netilmicin Sulfate Reagent Market Research Report 2024

Ampicillin Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Systemic Antibiotics Market Research Report 2024

Global Lincomycin Antibiotics Market Research Report 2024

Global Topical Antibiotics Market Research Report 2024

Global Amoxicillin Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions